Theodore James Washburn Jr. Agios Pharmaceuticals, Inc. (AGIO) insider trading activity

Theodore James Washburn Jr. is Principal Accounting Officer of AGIOS PHARMACEUTICALS, INC.. Currently has a direct ownership of 868 shares of AGIO, which is worth approximately $31,925. The most recent transaction as insider was on Sep 05, 2025, when has been sold 8,546 shares (Common Stock) at a price of $36.87 per share, resulting in proceeds of $315,091. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 868

90.78% 3M change

43.04% 12M change

Total Value Held $31,925

Theodore James Washburn Jr. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 05 2025	SELL Open market or private sale	$315,091 $36.87 p/Share	8,546 Reduced 90.78%	868 Common Stock
Mar 03 2025	SELL Open market or private sale	$58,818 $35.54 p/Share	1,655 Reduced 14.95%	9,414 Common Stock
Mar 01 2025	BUY Exercise of conversion of derivative security	-	5,577 Added 35.48%	10,141 Common Stock
Feb 05 2025	SELL Open market or private sale	$78,134 $34.39 p/Share	2,272 Reduced 29.47%	5,437 Common Stock
Feb 01 2025	BUY Exercise of conversion of derivative security	-	6,896 Added 47.22%	7,709 Common Stock
Nov 08 2024	SELL Open market or private sale	$43,301 $56.09 p/Share	772 Reduced 48.71%	813 Common Stock
Jun 03 2024	SELL Open market or private sale	$60,459 $44.39 p/Share	1,362 Reduced 47.19%	1,524 Common Stock
Mar 05 2024	SELL Open market or private sale	$60,737 $31.75 p/Share	1,913 Reduced 39.86%	2,886 Common Stock
Mar 05 2024	SELL Open market or private sale	$39,539 $32.57 p/Share	1,214 Reduced 20.19%	4,799 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	-	3,127 Added 35.35%	5,718 Common Stock
Feb 20 2024	SELL Open market or private sale	$13,421 $26.63 p/Share	504 Reduced 15.53%	2,741 Common Stock
Feb 14 2024	SELL Open market or private sale	$6,863 $25.14 p/Share	273 Reduced 7.76%	3,245 Common Stock
Feb 12 2024	BUY Exercise of conversion of derivative security	-	777 Added 18.09%	3,518 Common Stock
Aug 07 2023	SELL Open market or private sale	$74,088 $25.39 p/Share	2,918 Reduced 51.56%	2,741 Common Stock
Aug 01 2023	SELL Open market or private sale	$32,352 $26.26 p/Share	1,232 Reduced 17.88%	5,659 Common Stock
Aug 01 2023	BUY Exercise of conversion of derivative security	-	4,150 Added 37.59%	6,891 Common Stock
Mar 03 2023	SELL Open market or private sale	$12,242 $24.29 p/Share	504 Reduced 15.53%	2,741 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$6,909 $25.31 p/Share	273 Reduced 7.76%	3,245 Common Stock
Mar 01 2023	BUY Exercise of conversion of derivative security	-	777 Added 18.09%	3,518 Common Stock
Feb 16 2023	SELL Open market or private sale	$6,339 $27.21 p/Share	233 Reduced 8.03%	2,668 Common Stock
Feb 14 2023	SELL Payment of exercise price or tax liability	$3,671 $28.91 p/Share	127 Reduced 3.6%	3,405 Common Stock
Feb 14 2023	SELL Open market or private sale	$14,409 $28.59 p/Share	504 Reduced 14.8%	2,901 Common Stock
Feb 14 2023	SELL Payment of exercise price or tax liability	$7,764 $28.44 p/Share	273 Reduced 7.92%	3,172 Common Stock
Feb 14 2023	BUY Exercise of conversion of derivative security	-	360 Added 9.25%	3,532 Common Stock
Feb 10 2023	BUY Exercise of conversion of derivative security	-	777 Added 18.4%	3,445 Common Stock

TJW

Theodore James Washburn Jr.

Principal Accounting Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGIO shares.

Notify only if

Value

Insider Trading

Get notified when an Agios Pharmaceuticals, Inc. insider buys or sells AGIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to AGIOS PHARMACEUTICALS, INC.

Track Activities on AGIO

Account